ArticleAsian Pacific journal of cancer prevention : APJCP2024

Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study.

Tu Anh Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.